Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition • 09-14 May 2026

Traditional Poster

Quantitative and Diffusion MRI of the Liver

Back to the Program-at-a-Glance

Quantitative and Diffusion MRI of the Liver
Traditional Poster
Body
Wednesday, 13 May 2026
Traditional Posters | Exhibition Hall
09:15 - 10:10
Session Number: 570-04
No CME/CE Credit
This session includes presentations discussing the latest advances in MRI of the liver.
Skill Level: Intermediate

  Figure 570-04-189.  Liver PDFF and water T1 and T2 mapping in a single breath hold using multi-echo phase-cycled bSSFP
Joseph Woods, Nils Plähn, Matteo Tagliabue, Berk Acikgoz, Eva Peper, Naik Vietti-Violi, Verena Obmann, Adrian Huber, Roland Kreis, Jessica Bastiaansen
Inselspital, Bern University Hospital, University of Bern, Switzerland
Impact: The proposed technique allows for fast and accurate fat-fraction measurements and water-specific T1 & T2 mapping in the liver, potentially providing a valuable clinical tool for the diagnosis and monitoring of liver disease, which currently affects 25% of the worldwide population.
  Figure 570-04-190.  Robust free breathing liver diffusion-weighted imaging
Anh Van, Marco Mueller, Jean-Baptiste LEDOUX, Clarisse Dromain, Ruud van Heeswijk, Matthias Stuber, Naik Vietti-Violi
Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland
Impact: The proposed algorithm for slice alignment and motion-induced signal loss mitigation enables robust free breathing liver DWI.
  Figure 570-04-191.  Assessment of Liver Fibrosis: Comparison of Gd-EOB-DTPA-enhanced T1 mapping and Diffusion Kurtosis Imaging
Li Yang, Robert Grimm, Caixia Fu
Zhongshan Hospital, Fudan University, Shanghai, China
Impact: Diffusion Kurtosis Imaging offers similar diagnostic performance to Gd-EOB-DTPA-enhanced T1 mapping in staging liver fibrosis
  Figure 570-04-192.  Restricted Spectrum Imaging for Diagnosis of High-Risk Metabolic Dysfunction-Associated Steatohepatitis
Jie Yuan, HAIYU HUANG, Zhiwei Qin, Sun Yuejun, Wenli Tan, Songhua Zhan
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China
Impact: RSI provides clinicians with a novel quantitative MRI biomarker for high-risk MASH diagnosis, potentially reducing reliance on invasive liver biopsies. This multi-compartmental approach enables investigation of hepatic microstructural changes and may guide treatment stratification in high-risk MASH patients.
  Figure 570-04-193.  Susceptibility Separation Reveals Hepatic Paramagnetic and Diamagnetic Alterations in Type 2 Diabetes Mellitus
Jing He, Jingwen Luo, Liya Gong, Ziqi Wu, Zhujia Li, wei cui, Junyan Wen, Ge Wen
Nanfang Hospital, Southern Medical University, Guangzhou, China
Impact: Susceptibility separation QSM enables disentangling hepatic paramagnetic and diamagnetic components, revealing diamagnetic susceptibility reduction in T2DM patients. This technique provides a new biomarker to monitor metabolic liver alterations.
  Figure 570-04-194.  Inter-patient heterogeneity of T1 and T2 relaxation times and visibility of liver metastases treated on an MR-linac
Osman Akdag, Vivian W. J. van Pelt, Robin Navest, Ruben Bosschaert, Ben Neijndorff, Marlies E Nowee, Tomas Janssen, Jan-Jakob Sonke, Ulke van der Heide, Petra van Houdt
the Netherlands Cancer Institute, Amsterdam, Netherlands
Impact: Our approach demonstrated that imaging contrast between liver metastases and liver can be improved with an average[range] of 142%[17%-3484%] without a contrast agent. The increased contrast can facilitate accurate delineations and online guidance for improved MRI-guided stereotactic body radiation therapy.
  Figure 570-04-195.  In-vivo Multiparametric Imaging and PDFF in the Liver at 0.1 T: Initial Results
Dorothy Twum, Gabriel Zihlmann, Mathieu Sarracanie, Najat Salameh
University of Aberdeen, Aberdeen, United Kingdom
Impact: We demonstrated the feasibility of water-fat separation and multiparametric imaging in the liver at very low field (≤0.1T). Once optimized and validated, these approaches could enable early MASLD diagnosis and intervention in underserved communities where prevalence is rapidly increasing.
  Figure 570-04-196.  Accelerated Water-Specific T1 Mapping of the Liver Using Multiband Chemical-Shift-Encoded MOLLI
Josh Greer, Giulio Ferrazzi, Johannes Peeters, Mary Kate Manhard, Matt Lanier, Andrew Trout, Jonathan Dillman, Amol Pednekar
Philips Healthcare (Cincinnati), Cincinnati, United States of America
Impact: Multiband cseMOLLI enables rapid, water-specific T1 mapping of the entire liver in two breath-holds. By increasing spatial coverage without lengthening scan time, this technique supports comprehensive, quantitative assessment for clinical and research applications in diffuse liver disease.
  Figure 570-04-197.  Hepatosplenic Stiffness in Pediatric Cystic Fibrosis: Cross-Validation of MR Elastography and Ultrasound Elastography
Matthias Anders, Yuliya Sharkovska, Tom Meyer, Federico Mollica, Ingolf Sack, Simon Veldhoen, Corona Metz
Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
Impact: MR elastography differentiated pediatric cystic fibrosis patients with hepatic fibrosis or steatosis from those without liver involvement, based on liver and spleen stiffness. Findings were validated by ultrasound-based time-harmonic elastography and transient shear-wave elastography, enabling comprehensive non-invasive hepatosplenic stiffness evaluation.

Back to the Program-at-a-Glance

© 2026 International Society for Magnetic Resonance in Medicine